timothy sykes logo
FLR Surges As Fluor Posts Big Q2 Beat And Boosts Backlog Thumbnail
G Google News

FLR Surges As Fluor Posts Big Q2 Beat And Boosts Backlog

TIM SYKES•UPDATED AUG. 9, 2026, 10:08 AM ET
Reviewed by Jack Kelloggand Fact-checked by Ellis Hobbs

Fluor Corporation stocks have been trading up by 16.25 percent after securing major new infrastructure contracts that boosted investor confidence.

What Traders Need To Know

  • Q2 2026 saw adjusted EPS of $0.91 on roughly $4.3B–$4.33B revenue, beating estimates and more than doubling earnings versus last year, sparking a sharp positive re-rate.
  • New awards of $6.1B pushed backlog to $26.9B, mostly reimbursable work, improving revenue visibility and lowering contract risk for traders watching future quarters.
  • A $175M sale of the ICA-Fluor Daniel Mexico JV front-loads value; the gain plus year-to-date income tops the JV’s expected full-year 2026 earnings contribution.
  • FY26 adjusted EBITDA guidance was trimmed to $500M–$525M from $525M–$560M after removing the Mexico JV, while core segments, especially Energy Solutions and Mission Solutions, strengthened.
  • The company is positioned as a key “pick-and-shovel” play on nuclear and SMR buildout and secured a FEED win in Bahrain, reinforcing the growth pipeline.

Candlestick Chart

Weekly Update Aug 03 – Aug 07, 2026: On Sunday, August 09, 2026 Fluor Corporation stock [NYSE: FLR] is trending up by 16.25%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Industrials industry expert:

Analyst sentiment – positive

Fluor sits in a clear fundamental recovery phase, with Q2 revenue of $4.33B and trailing revenue growth near 2% annually but still burdened by structurally thin margins (EBIT margin ~2.5%, gross margin negative on legacy mix). ROE is improving (LTM ~11%) on modest leverage (total debt/equity 0.37, current ratio 1.8) and a strong cash position of $2.9B, yet cash generation is volatile, with Q2 operating cash flow of -$317M and free cash flow of -$324M amid heavy working-capital swings and $300M buybacks.

Technically, FLR has broken sharply higher, from ~50 on 8/6 to a 56.67 close on 8/7 after the Q2 beat, confirming a bullish reversal on the weekly tape. The 48–50 area is now the dominant support zone and prior consolidation base, with clear evidence of elevated post-earnings volume and aggressive dip buying intraday. The actionable trading level is $50: above it, long bias with a first resistance target at $58–60; a sustained close below $50 invalidates the near-term uptrend.

Fundamentally and relative to Industrials and Construction peers, Fluor’s improving backlog quality ($26.9B, predominantly reimbursable), NuScale monetization, ICA-Fluor JV exit, and Bahrain FEED award support a higher-quality earnings mix than pre-turnaround, despite modestly trimmed 2026 EBITDA guidance ($500–525M). With execution momentum, strong award inflows, and an aggressive $1.4B 2026 buyback, risk/reward remains favorable. I see near-term resistance at $60 and medium-term upside toward $65, with firm support at $50.

More Breaking News

Quick Financial Overview

Fluor Corporation just printed a strong Q2 2026, with revenue of about $4.33B and adjusted EPS of $0.91, beating consensus on both lines. Revenue grew 9%, and new awards surged to $6.1B, lifting backlog to $26.9B that is largely reimbursable, which matters because it reduces cost overrun risk. For traders, that combination of beats plus higher-quality backlog explains why the stock ripped higher after earnings.

On the weekly chart, FLR moved from the low $50s early in the week to close near $56.67 by 2026/08/07, a powerful upside range expansion. Intraday, a 5-minute bar showing a push from the mid-$54s to a high near $57 with strong close indicates aggressive dip buying and short covering after the Q2 print. This is classic post-earnings momentum: wide intraday range, strong close near highs, and confirmation from multi-day follow-through.

Fundamentals back the move but are not perfect. Margins are still thin, with EBIT margin around 2.5% and profit margins near 2% despite $15.5B in trailing revenue. The P/E near 32.4 and price-to-book around 2.77 tell you the market is paying up for improving execution, nuclear/SMR leverage, and a cleaner backlog. Balance sheet strength is decent, with current ratio of 1.8, debt-to-equity at 0.37, and over $2.9B in cash, giving Fluor Corporation room to keep funding buybacks and strategic pivots.

Conclusion

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”